Principios básicos para prescribir la diálisis peritoneal crónica
Resumen
La diálisis peritoneal, como tratamiento sustitutivo de la función renal, se basa en la instilación dentro de la cavidad peritoneal de soluciones de diálisis con el objeto de aprovechar algunas de las propiedades del peritoneo como membrana biológica, con el fin de eliminar las sustancias de desecho generadas diariamente por nuestro organismo y contribuir entre otros con el control del balance hidrosalino alterado en la insuficiencia renal.Citas
Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK. Continuous ambulatory peritoneal dialysis. Ann Intern Med. 1978;88(4):449-56.
Fusshöller A, zur Nieden S, Grabensee B, Plum J. Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence. J Am Soc Nephrol. 2002;13(4):1055-60.
Cnossen TT, Konings CJ, Van der Sande FM, Leunissen KM, Kooman JP. Clinical effects of icodextrin in peritoneal dialysis. NDT Plus. 2008;1(Suppl 4):iv18-iv22.
Gokal R, Moberly J, Lindholm B, Mujais S. Metabolic and laboratory effects of icodextrin. Kidney Int Suppl. 2002;(81):S62-71.
García-López E, Pawlaczyk K, Anderstam B, Qureshi AR, Kuzlan-Pawlaczyk M, Heimbürger O, et al. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis. Perit Dial Int. 2007;27(4):415-23.
Bruno M, Bagnis C, Marangella M, Rovera L, Cantaluppi A, Linari F. CAPD with an amino acid dialysis solution: a long-term, cross-over study. Kidney Int. 1989;35(5):1189-94.
Plum J, Erren C, Fieseler C, Kirchgessner J, Passlick-Deetjen J, Grabensee B. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study. Perit Dial Int. 1999;19(5):418-28.
Buijsen CG, Struijk DG, Huijgen HJ, Boeschoten EW, Wilmink JM. Can low-calcium peritoneal dialysis solution safely replace the standard calcium solution in the majority of chronic peritoneal dialysis patients? Perit Dial Int. 1996;16(5):497-504.
Twardowski ZJ, Nolph KO, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Int. 1987;7(3):138-48.
Buoncristiani U. The Y set with disinfectant is here to stay. Perit Dial Int. 1989;9(3):149-50.
Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Broccoli R, Graziani G, et al. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet. 1983;2(8351):642-4.
Canadian CAPD Clinical Trials Group. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int. 1989;9(3):159-63.
Gokal R, Hutchison A. Dialysis therapies for end-stage renal disease. Semin Dial. 2002;15(4):220-6.
Juergensen PH, Murphy AL, Pherson KA, Kliger AS, Finkelstein FO. Tidal peritoneal dialysis: comparison of different tidal regimens and automated peritoneal dialysis. Kidney Int. 2000;57(6):2603-7.
Vychytil A, Hörl WH. The role of tidal peritoneal dialysis in modern practice: A European perspective. Kidney Int Suppl. 2006;(103):S96-S103.
Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5):1307-20.
Lo WK, Ho YW, Li CS, Wong KS, Chan TM, Yu AW, et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int. 2003;64(2):649-56.
Lo WK, Bargman JM, Burkart J, Krediet RT, Pollock C, Kawanishi H, et al. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int. 2006;26(5):520-2.
Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980;33(1):27-39.
Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition. 1989;5(5):303-11.
Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol. 1996;7(2):198-207.
Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans. 1991;37(4):598-604.
Keshaviah P, Emerson PF, Vonesh EF, Brandes JC. Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis. J Am Soc Nephrol. 1994;4(10):1820-6.
Hufnagel G, Michel C, Queffeulou G, Skhiri H, Damieri H, Mignon F. The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant. 1999;14(5):1224-8.
Julian Mauro JC, Molinuevo Tobalina JA, Sánchez González JC. La situación laboral del paciente con enfermedad renal crónica en función del tratamiento sustitutivo renal. Nefrologia. 2012;32(4):439-45.
Muehrer RJ, Schatell D, Witten B, Gangnon R, Becker BN, Hofmann RM. Factors affecting employment at initiation of dialysis. Clin J Am Soc Nephrol. 2011;6(3):489-96.
Badve SV, Hawley CM, McDonald SP, Mudge DW, Rosman JB, Brown FG, et al. Automated and continuous ambulatory peritoneal dialysis have similar outcomes. Kidney Int. 2008;73(4):480-8.
Rao CS, Charan P, Naidu GD, Swarnalatha G, Ram R, Dakshinamurty KV. A 2-year follow-up study of patients on automated peritoneal dialysis. Indian J Nephrol. 2013;23(5):327-31.
Piraino B, Sheth H. Peritonitis - does peritoneal dialysis modality make a difference? Blood Purif. 2010;29(2):145-9.
Barone RJ, Cámpora MI, Gimenez NS, Ramirez L, Panese SA, Santopietro M. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis and peritonitis in the short and very long term at risk. Adv Perit Dial. 2012;28:44-9.
